These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24773698)

  • 1. Duration between onset and diagnosis in central nervous system tumors: impact on prognosis and functional outcome.
    Fukuoka K; Yanagisawa T; Suzuki T; Shirahata M; Adachi JI; Mishima K; Fujimaki T; Matsutani M; Nishikawa R
    Pediatr Int; 2014 Dec; 56(6):829-833. PubMed ID: 24773698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation and symptom interval in children with central nervous system tumors. A single-center experience.
    Stocco C; Pilotto C; Passone E; Nocerino A; Tosolini R; Pusiol A; Cogo P
    Childs Nerv Syst; 2017 Dec; 33(12):2109-2116. PubMed ID: 28808765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Symptom to Diagnosis-The Prediagnostic Symptomatic Interval of Pediatric Central Nervous System Tumors in Austria.
    Azizi AA; Heßler K; Leiss U; Grylli C; Chocholous M; Peyrl A; Gojo J; Slavc I
    Pediatr Neurol; 2017 Nov; 76():27-36. PubMed ID: 28935367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding the Needle in the Hay Stack: Population-based Study of Prediagnostic Symptomatic Interval in Children With CNS Tumors.
    Goldman RD; Cochrane DD; Dahiya A; Mah H; Buttar A; Lambert C; Cheng S
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1093-e1098. PubMed ID: 33235150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenting symptoms and time to diagnosis for Pediatric Central Nervous System Tumors in Qatar: a report from Pediatric Neuro-Oncology Service in Qatar.
    Maaz AUR; Yousif T; Saleh A; Pople I; Al-Kharazi K; Al-Rayahi J; Elkum N; Malik M
    Childs Nerv Syst; 2021 Feb; 37(2):465-474. PubMed ID: 32710251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.
    Gerber NU; von Hoff K; von Bueren AO; Treulieb W; Deinlein F; Benesch M; Zwiener I; Soerensen N; Warmuth-Metz M; Pietsch T; Mittler U; Kuehl J; Kortmann RD; Grotzer MA; Rutkowski S
    Eur J Cancer; 2012 Sep; 48(13):2028-36. PubMed ID: 22153558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions.
    Arnautovic A; Billups C; Broniscer A; Gajjar A; Boop F; Qaddoumi I
    Childs Nerv Syst; 2015 Jul; 31(7):1067-77. PubMed ID: 25742877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic delay and morbidity of central nervous system tumors in children and young adults: a pediatric hospital experience.
    Patel V; McNinch NL; Rush S
    J Neurooncol; 2019 Jun; 143(2):297-304. PubMed ID: 30929127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Central Nervous System Tumors in Nepal: Retrospective Analysis and Literature Review of Low- and Middle-Income Countries.
    Azad TD; Shrestha RK; Vaca S; Niyaf A; Pradhananga A; Sedain G; Sharma MR; Shilpakar SK; Grant GA
    World Neurosurg; 2015 Dec; 84(6):1832-7. PubMed ID: 26283488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
    Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
    Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathological spectrum of solid CNS metastases in the pediatric population.
    Wiens AL; Hattab EM
    J Neurosurg Pediatr; 2014 Aug; 14(2):129-35. PubMed ID: 24926970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in children with central nervous system tumors disseminated at presentation: a large single-center experience.
    Kirkman MA; Hayward R; Phipps K; Aquilina K
    Childs Nerv Syst; 2018 Nov; 34(11):2259-2267. PubMed ID: 29938304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health disparities and impact on outcomes in children with primary central nervous system solid tumors.
    Austin MT; Hamilton E; Zebda D; Nguyen H; Eberth JM; Chang Y; Elting LS; Sandberg DI
    J Neurosurg Pediatr; 2016 Nov; 18(5):585-593. PubMed ID: 27540957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient- and parent-reported diagnostic delay in children with central nervous system tumors in Denmark.
    Weile KS; Helligsoe ASL; von Holstein SL; Winther JF; Mathiasen R; Hasle H; Henriksen LT
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31128. PubMed ID: 38814259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis of clinical course of primary brain tumours in children in relationship to the duration and characteristic features of initial clinical symptoms].
    Zalewska-Szewczyk B; Zielińska E; Zakrzewski K; Bulas M; Andrzejewski W; Bodalski J
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):567-78. PubMed ID: 16719170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of children and adolescents with central nervous system tumors in phase I trials.
    Carceller F; Bautista F; Jiménez I; Hladun-Álvaro R; Giraud C; Bergamaschi L; Dandapani M; Aerts I; Doz F; Frappaz D; Casanova M; Morland B; Hargrave DR; Vassal G; Pearson ADJ; Geoerger B; Moreno L; Marshall LV
    J Neurooncol; 2018 Mar; 137(1):83-92. PubMed ID: 29236237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary central nervous system tumor treatment and survival in the United States, 2004-2015.
    Garcia CR; Slone SA; Dolecek TA; Huang B; Neltner JH; Villano JL
    J Neurooncol; 2019 Aug; 144(1):179-191. PubMed ID: 31254264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system gangliogliomas. Part 2: Clinical outcome.
    Lang FF; Epstein FJ; Ransohoff J; Allen JC; Wisoff J; Abbott IR; Miller DC
    J Neurosurg; 1993 Dec; 79(6):867-73. PubMed ID: 8246055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cavernous malformations of the central nervous system in the pediatric age group.
    Acciarri N; Galassi E; Giulioni M; Pozzati E; Grasso V; Palandri G; Badaloni F; Zucchelli M; Calbucci F
    Pediatr Neurosurg; 2009; 45(2):81-104. PubMed ID: 19307743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
    Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.